Q-omics provides the consensus-scored MIR4263 profile across patient tissues and cancer cell-line models. MIR4263 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in BLCA. Among the 18 cancer types available for tumor–normal comparison, MIR4263 is differentially expressed in 13, with the highest sampling consensus in LUAD. Additionally, MIR4263 RNA expression shows 17,110 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight BLCA, LUAD, and UVM as cancer lineages where MIR4263 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR4263 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR4263 survival associations across molecular data types. MIR4263 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR4263 RNA expression–survival associations across cancer types. High MIR4263 expression shows unfavorable associations in BLCA and HNSC, but favorable associations in BRCA, OV, UCS and ESCA. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for MIR4263 RNA expression.
This table summarizes MIR4263 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 13. The strongest signals are observed in LUAD for RNA.
This table ranks reproducible tumor–normal expression differences for MIR4263. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR4263 shows lower tumor expression in KICH and KIRC and higher tumor expression in LUAD, HNSC, BRCA and LUSC. The LUAD box plot shows higher MIR4263 RNA expression in tumor versus normal tissue (log2 FC = +1.245, t-test p < 0.001).
This table shows molecular features associated with MIR4263 in patient tissues and cancer cell lines. In patient samples, MIR4263 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
